Activity measures of the lower limb (lower limb activity) · rehabilitation vs less time spent
1 finding from 1 review
Motor impairment measures of the upper limb (upper limb impairment) · rehabilitation vs less time spent
1 finding from 1 review
Motor impairment measures of the lower limb (lower limb impairment) · rehabilitation vs less time spent
1 finding from 1 review
Serious adverse events/death · rehabilitation vs less time spent
Summary of findings table ‐ More time showed no clear difference in serious adverse events/death compared with less time (low certainty).
1 finding from 1 review
ADL outcome · rehabilitation (medium‐term outcomes)
1 finding from 1 review
Activity measures of the upper limb (upper limb activity) · rehabilitation (medium‐term outcomes)
1 finding from 1 review
Activity measures of the lower limb (lower limb activity) · rehabilitation (medium‐term outcomes)
1 finding from 1 review
MACE · adults within 180 days of non‐cardioembolic ischaemic stroke or transient ischaemic attack and a clinical history of prior intracerebral…
Summary of findings table ‐ Cilostazol showed no clear difference in MACE compared with aspirin (low certainty).
1 finding from 1 review
Death · adults within 180 days of non‐cardioembolic ischaemic stroke or transient ischaemic attack and a clinical history of prior intracerebral…
Summary of findings table ‐ Cilostazol showed no clear difference in death compared with aspirin (low certainty).
1 finding from 1 review
All major occlusive vascular events · adults within 180 days of non‐cardioembolic ischaemic stroke or transient ischaemic attack and a clinical history of prior intracerebral…
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Intracerebral haemorrhage (ICH) · adults within 180 days of non‐cardioembolic ischaemic stroke or transient ischaemic attack and a clinical history of prior intracerebral…
Summary of findings table ‐ Cilostazol showed no clear difference in intracerebral haemorrhage (ICH) compared with aspirin (low certainty).
1 finding from 1 review
Functional status ‐ not reported · adults within 180 days of non‐cardioembolic ischaemic stroke or transient ischaemic attack and a clinical history of prior intracerebral…
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Dead or dependent · acute presumed ischaemic stroke
Summary of findings table ‐ Anticoagulant showed no clear difference in dead or dependent at end of compared with control (high certainty).
1 finding from 1 review
Death during study period · acute presumed ischaemic stroke
Summary of findings table ‐ Anticoagulant showed no clear difference in death from all causes during treatment period compared with control (low certainty).
1 finding from 1 review
Deep vein thrombosis · acute presumed ischaemic stroke
It is very uncertain whether summary of findings table ‐ Anticoagulant changes deep vein thrombosis during treatment period compared with control (very low certainty).
1 finding from 1 review
Recurrent ischaemic or unknown stroke during treatment period · acute presumed ischaemic stroke
Summary of findings table ‐ Anticoagulant probably leads to lower recurrent ischaemic or unknown stroke during treatment period compared with control (moderate certainty).
1 finding from 1 review
Symptomatic intracranial haemorrhage during treatment period · acute presumed ischaemic stroke
Summary of findings table ‐ Anticoagulant probably leads to higher symptomatic intracranial haemorrhage during treatment period compared with control (moderate certainty).
1 finding from 1 review
Symptomatic PE · acute presumed ischaemic stroke
Summary of findings table ‐ Anticoagulant leads to lower symptomatic pulmonary embolism during treatment period compared with control (high certainty).
1 finding from 1 review
Major extracranial haemorrhage during treatment period · acute presumed ischaemic stroke
Summary of findings table ‐ Anticoagulant probably leads to higher major extracranial haemorrhage during treatment period compared with control (moderate certainty).
1 finding from 1 review
ADL outcome · people with stroke
2 findings from 1 review